Cannabis Sativa, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 16, 2020 at 12:59 pm EST
Share
Cannabis Sativa, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was USD 459,786 compared to USD 453,653 a year ago. Operating loss was USD 664,908 compared to USD 453,046 a year ago. Net loss was USD 558,524 compared to USD 570,407 a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.03 a year ago. For the nine months, sales was USD 1.674 million compared to USD 704,998 a year ago. Operating loss was USD 1.796 million compared to USD 1.729 million a year ago. Net loss was USD 1.665 million compared to USD 1.804 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.08 a year ago.
Cannabis Sativa, Inc. is engaged in telehealth through its 51% owned subsidiary and the licensing of cannabis-related intellectual property (IP), marketing and branding for cannabis-based products and services, operation of cannabis-related technology services, and ancillary business activities. It operates through various subsidiaries, including PrestoCorp, Inc. (PrestoCorp), Wild Earth Naturals, Inc., Kubby Patent and Licenses Limited Liability Company, Hi Brands, International, Inc., Eden Holdings LLC, and iBudtender, Inc., GK Manufacturing and Packaging, Inc. PrestoCorp offers an online telemedicine platform providing customer access to knowledgeable physicians to obtain a medical marijuana recommendation. PrestoCorp uses video conferencing technology to provide a safe and confidential forum for the doctor patient interview in accordance with state regulations governing issuance of medical marijuana cards. It offers services in California, Nevada, New York, Missouri, and Oklahoma.
CANNABIS SATIVA, INC. 
